Efficacy of eribulin mesylate in HER2-low and HER2-0 metastatic breast cancer (MBC): Results from an analysis of two phase 3 studiesChris Twelves,Peter A. Kaufman,Ahmad Awada,Seock-Ah Im,Bagrat Lalayan, Ran Xie,Linda T. Vahdat,Javier CortesCANCER RESEARCH(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要